Technical Analysis for PRCT - PROCEPT BioRobotics Corporation
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| New Uptrend | Bullish | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 1.28% | |
| Multiple of Ten Bullish | Other | 1.28% | |
| Oversold Stochastic | Weakness | 1.28% | |
| Multiple of Ten Bearish | Other | 3.58% |
| Alert | Time |
|---|---|
| 50 DMA Resistance | about 7 hours ago |
| Rose Above Previous Day's High | about 9 hours ago |
| Rose Above 50 DMA | about 9 hours ago |
| Up 3% | about 9 hours ago |
| Up 2% | about 9 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 07/25/2024
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is based in Redwood City, California.
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine IBD 50 Urology Benign Prostatic Hyperplasia Minimally Invasive Surgery Robot Assisted Surgery Bph Urologic Surgery
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine IBD 50 Urology Benign Prostatic Hyperplasia Minimally Invasive Surgery Robot Assisted Surgery Bph Urologic Surgery
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 77.0 |
| 52 Week Low | 24.83 |
| Average Volume | 649,906 |
| 200-Day Moving Average | 46.25 |
| 50-Day Moving Average | 62.26 |
| 20-Day Moving Average | 63.40 |
| 10-Day Moving Average | 60.24 |
| Average True Range | 2.22 |
| RSI (14) | 48.45 |
| ADX | 25.94 |
| +DI | 22.66 |
| -DI | 20.65 |
| Chandelier Exit (Long, 3 ATRs) | 62.65 |
| Chandelier Exit (Short, 3 ATRs) | 64.45 |
| Upper Bollinger Bands | 70.55 |
| Lower Bollinger Band | 56.24 |
| Percent B (%b) | 0.39 |
| BandWidth | 22.58 |
| MACD Line | -0.99 |
| MACD Signal Line | -0.53 |
| MACD Histogram | -0.457 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 64.78 | ||||
| Resistance 3 (R3) | 64.89 | 64.02 | 64.30 | ||
| Resistance 2 (R2) | 64.02 | 63.28 | 63.97 | 64.13 | |
| Resistance 1 (R1) | 62.95 | 62.82 | 63.49 | 62.84 | 63.97 |
| Pivot Point | 62.08 | 62.08 | 62.35 | 62.03 | 62.08 |
| Support 1 (S1) | 61.01 | 61.34 | 61.55 | 60.90 | 59.77 |
| Support 2 (S2) | 60.14 | 60.88 | 60.09 | 59.61 | |
| Support 3 (S3) | 59.07 | 60.14 | 59.45 | ||
| Support 4 (S4) | 58.96 |
